Cargando…

Influence of Dapagliflozin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Objectives. To observe changes in blood glycemic variations and oxidative stress level before and after dapagliflozin treatment in patients with newly diagnosed T2DM. Methods. This was a randomized, double-blind, placebo-controlled, phase 3 trial. A total of 28 patients with newly diagnosed T2DM wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Feng-fei, Gao, Gu, Li, Qian, Zhu, Hong-hong, Su, Xiao-fei, Wu, Jin-dan, Ye, Lei, Ma, Jian-hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050380/ https://www.ncbi.nlm.nih.gov/pubmed/27738639 http://dx.doi.org/10.1155/2016/5347262

Ejemplares similares

Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open-Labeled Trial
por: Jiang, Lan-lan, et al.
Publicado: (2021)

Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
por: Li, Feng-fei, et al.
Publicado: (2017)

Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes
por: Liu, Bing-li, et al.
Publicado: (2018)

Impaired β Cell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia
por: Ma, Yuhang, et al.
Publicado: (2014)

Serum ErbB2 concentration positively correlated to the glycemic variations in newly diagnosed Type 2 diabetic patients
por: Huang, Yan, et al.
Publicado: (2022)

Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA(1c) values
por: Li, Feng-fei, et al.
Publicado: (2017)

Greater Glycemic Burden Is Associated with Further Poorer Glycemic Control in Newly-Diagnosed Type 2 Diabetes Mellitus Patients
por: Wen, Wei-Lun, et al.
Publicado: (2022)

Abstract 52: Clinical efficacy of dapagliflozin in patients with newly diagnosed type 2 diabetes
por: Patil, Surekha Mahesh
Publicado: (2022)

Antihypertensive treatment improves glycemic control in patients with newly diagnosed type 2 diabetes mellitus: A prospective cohort study
por: Li, Jung-Chi, et al.
Publicado: (2022)

Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study
por: Ke, Weijian, et al.
Publicado: (2016)

Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy
por: Li, Feng-fei, et al.
Publicado: (2018)

Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control
por: Lam, Pun Yuet, et al.
Publicado: (2021)

Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
por: Li, Feng-fei, et al.
Publicado: (2017)

Effect of Linagliptin on Glycemic Control in Chinese Patients with Newly-Diagnosed, Drug-Naïve Type 2 Diabetes Mellitus: A Randomized Controlled Trial
por: Wu, Wenjun, et al.
Publicado: (2015)

Effects of Dapagliflozin and Sitagliptin on Insulin Resistant and Body Fat Distribution in Newly Diagnosed Type 2 Diabetic Patients
por: Sun, Yue, et al.
Publicado: (2020)

The Factors Influencing the Renal Glucose Threshold in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Cui, Shan-Shan, et al.
Publicado: (2021)

Glycemic variation in uncontrolled Graves’ disease patients with normal glucose metabolism: Assessment by continuous glucose monitoring
por: Gao, Gu, et al.
Publicado: (2018)

SKAP2, a Candidate Gene for Type 1 Diabetes, Regulates β-Cell Apoptosis and Glycemic Control in Newly Diagnosed Patients
por: Fløyel, Tina, et al.
Publicado: (2021)

Changes in glycemic control and skeletal muscle mass indices after dapagliflozin treatment in individuals with type 1 diabetes mellitus
por: Yoshimura, Yuta, et al.
Publicado: (2023)

Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study
por: Li, Feng-fei, et al.
Publicado: (2015)

Effect of Poor Glycemic Control in Newly Diagnosed Patients with Smear-Positive Pulmonary Tuberculosis and Type-2 Diabetes Mellitus
por: Mahishale, Vinay, et al.
Publicado: (2017)

Medication adherence and glycemic control among newly diagnosed diabetes patients
por: Lin, Lee-Kai, et al.
Publicado: (2017)

The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients
por: Liu, Chenxiao, et al.
Publicado: (2016)

Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus
por: Watanabe, Yasuhiro, et al.
Publicado: (2018)

Depression in newly diagnosed type 2 diabetes
por: Yu, Ruan, et al.
Publicado: (2010)

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study
por: Shigiyama, Fumika, et al.
Publicado: (2017)

Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus
por: Kong, Sung Hye, et al.
Publicado: (2019)

Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial
por: Li, Feng-fei, et al.
Publicado: (2016)

Interstitial photodynamic therapy for newly diagnosed glioblastoma
por: Quach, Stefanie, et al.
Publicado: (2023)

The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial
por: Pan, Jiemin, et al.
Publicado: (2021)

Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Wan, Heng, et al.
Publicado: (2016)

Refractive errors in patients with newly diagnosed diabetes mellitus
por: Yarbağ, Abdülhekim, et al.
Publicado: (2015)

Influence of the Type of Basal Insulin and Other Variables on Clinical Outcomes in Children with Newly Diagnosed Type 1 Diabetes
por: Garrison, Ruth M., et al.
Publicado: (2014)

Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial
por: Yang, Xue, et al.
Publicado: (2023)

The influence of dapagliflozin on cardiac remodeling, myocardial function and metabolomics in type 1 diabetes mellitus rats
por: Rodrigues, Eder Anderson, et al.
Publicado: (2023)

Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
por: Ma, Fei, et al.
Publicado: (2022)

The Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes
por: Ma, Jing, et al.
Publicado: (2016)

Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus
por: Mu, Xiaodie, et al.
Publicado: (2023)

PRKAA2 variation and the clinical characteristics of patients newly diagnosed with type 2 diabetes mellitus in Yogyakarta, Indonesia
por: Virginia, Dita Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8jgo0rfc92ho6l3rvgtn1iv5qo